efocipegtrutide ( LAPS Triple agonist) efpegerglucagon ( LAPS Glucagon analog) HM97662 (EZH1/2 inhibitor) BH3120 (PD-L1/4-1BB BsAb) HM15275 (LA-GLP/GIP/GCG) HM16390 ( LAPS IL-2 analog) HM17321 (LA-UCN2) HM101207 (SOS1 inhibitor) LAPS Glucagon Combo HM15275 (LA-GLP/GIP/GCG) Overview As a long-acting glucagon-like peptide (GLP-1), gastric inhibitory peptide (GIP) and glucagon triple agonist, HM15275 achieves more favorable pharmacodynamics profile in addition to once-weekly dosing
a Three-point MACE was comprised of CV death, MI, and stroke
Products flagged included Keytruda, Ozempic, Rybelsus, Victoza, and tirzepatide, with the agency citing falsified lot numbers, missing active ingredients, contaminated products, and fraudulent packaging
Once-weekly semaglutide versus once-daily liraglutide for weight loss in adults: a Meta-analysis of randomized controlled trials